CompletedNot applicableNCT00478335

Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

Studying Arginine vasopressin resistance

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Colorado, Denver
Principal Investigator: Melissa A Cadnapaphornchai, MD, MD
University of Colorado, Denver
Intervention: sildenafil(drug)
Enrollment: 4 enrolled
Eligibility: 5-25 years · MALE
Timeline: 2007 – 2012

Study locations (2)

University of Colorado at Denver and Health Sciences Center, Aurora, Colorado, United States
University of Aarhus, Aarhus, Denmark

Collaborators

University of Aarhus

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00478335 on ClinicalTrials.gov

Other trials for Arginine vasopressin resistance

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE4NCT05044611
AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium
Assistance Publique - Hôpitaux de Paris

See all trials for Arginine vasopressin resistance →

← Back to all trials